German Tech Hardware Stock News

XTRA:SHL
XTRA:SHLMedical Equipment

Siemens Healthineers Wins Key US Clearances As Valuation Gap Widens

Siemens Healthineers (XTRA:SHL) received FDA clearance in the US for six new Artis interventional imaging systems featuring the Optiq AI imaging chain with deep-learning-based noise reduction. The company also secured renewed CDC HoSt-TT program certification for its Atellica IM Testosterone II assay, confirming its measurement accuracy in hormone testing. For readers tracking medical technology, Siemens Healthineers sits at the intersection of advanced imaging and diagnostic testing, two...
XTRA:JUN3
XTRA:JUN3Machinery

Assessing Jungheinrich (XTRA:JUN3) Valuation After Weaker First Quarter Earnings Results

First quarter earnings set the tone for Jungheinrich Jungheinrich (XTRA:JUN3) opened the new financial year with first quarter results showing sales of €1,272 million and net income of €26.2 million, both lower than the same period a year earlier. See our latest analysis for Jungheinrich. The Q1 earnings update has come against a weak share price backdrop, with Jungheinrich’s stock down 29.1% on a year to date share price return and the 1 year total shareholder return also declining 25.7%...
XTRA:EDL
XTRA:EDLEntertainment

European Dividend Stocks To Enhance Your Portfolio

The European market has recently experienced a volatile period, with the pan-European STOXX Europe 600 Index showing modest gains amid easing geopolitical tensions and strong corporate earnings, though tempered by tariff threats from the U.S. In this environment, dividend stocks can be an attractive option for investors seeking steady income streams and potential portfolio enhancement, especially as they offer a measure of stability against market fluctuations.
XTRA:BNR
XTRA:BNRTrade Distributors

Brenntag (XTRA:BNR) Margin Compression And One Off Loss Test Bullish Narratives In Q1 2026

Q1 2026 earnings snapshot and what it means for Brenntag (XTRA:BNR) Brenntag (XTRA:BNR) opened 2026 with Q1 revenue of €3.7b and basic EPS of €0.68, setting a fresh reference point for investors lining up the latest numbers against a share price of €61.64. Over recent quarters the company has seen revenue move from €4.1b in Q1 2025 to €3.9b in Q4 2025 and then to €3.7b in Q1 2026, while quarterly basic EPS shifted from €0.93 to a loss of €0.20 and then to €0.68. With trailing net profit...
XTRA:MRK
XTRA:MRKPharmaceuticals

Merck KGaA (XTRA:MRK) Margin Decline Challenges Bullish Profit Expansion Narrative

Merck KGaA (XTRA:MRK) has reported Q1 2026 revenue of €5.1b and basic EPS of €1.52, with the trailing twelve month figures sitting at €21.0b of revenue and EPS of €5.83. Over recent quarters, revenue has moved from €5.28b in Q1 2025 to €5.25b in Q2 2025, €5.32b in Q3 2025 and €5.25b in Q4 2025, while EPS shifted from €1.69 to €1.50, €2.07 and €0.73 across the same periods. This gives investors a clearer view of how the top and bottom line have tracked into this latest print. With a net profit...
XTRA:RWE
XTRA:RWERenewable Energy

RWE (XTRA:RWE) Q1 EPS Collapse Tests Long‑Term Renewables Growth Narrative

RWE (XTRA:RWE) opened 2026 with Q1 revenue of €4.3b and net income of €20m, translating to basic EPS of €0.03, against a trailing twelve month EPS of €3.27 on revenue of €16.3b and net income of €2.4b. The company has seen quarterly revenue move from €6.4b in Q1 2025 to €4.3b in Q1 2026, while basic EPS shifted from €1.07 to €0.03 over the same period. Trailing margins settled at a net profit level of 14.5%, setting up this result as a test of how much short term earnings softness investors...
XTRA:UN0
XTRA:UN0Renewable Energy

Uniper (XTRA:UN0) Valuation Check As Profitability Jumps Following Latest Earnings Release

Why Uniper’s latest earnings matter for shareholders Uniper (XTRA:UN0) just released first quarter 2026 results, with sales of €17,414 million compared with €21,341 million a year earlier, while net income moved to €335 million from €85 million. Basic earnings per share from continuing operations came in at €0.8 compared with €0.2 a year ago, putting profitability at the center of the current discussion around the stock. See our latest analysis for Uniper. At a share price of €43.75, Uniper’s...
XTRA:LEG
XTRA:LEGReal Estate

LEG Immobilien (XTRA:LEG) Q1 2026 EPS Drop Reinforces Bearish Earnings Narratives

LEG Immobilien (XTRA:LEG) has opened Q1 2026 with total revenue of €367.7 million and basic EPS of €1.03, giving investors a fresh datapoint after a year of very large earnings swings that were heavily influenced by one off items. The company has seen quarterly revenue move from €515.9 million in Q4 2024 to a range between €351.4 million and €468.7 million across 2025, while basic EPS shifted between €0.81 and €9.08 over the same period. This underscores just how volatile the income line has...
XTRA:AFX
XTRA:AFXMedical Equipment

Carl Zeiss Meditec (XTRA:AFX) Margin Compression To 4.4% Tests Bullish Earnings Recovery Narrative

Carl Zeiss Meditec (XTRA:AFX) has just posted its Q2 2026 numbers, with revenue at €524.0 million and basic EPS of €0.22, setting the tone for how investors might read the latest quarter. Over recent periods, revenue has moved between €560.0 million in Q2 2025 and €524.0 million in Q2 2026, while EPS has ranged from €0.52 in Q2 2025 to €0.22 in the latest quarter. This gives a clearer view of how the top line and per share earnings have tracked into this result. With trailing net profit...
XTRA:DEZ
XTRA:DEZMachinery

3 European Stocks That May Be Trading Below Their Estimated Value

The European market has recently seen modest gains, with the pan-European STOXX Europe 600 Index benefiting from easing geopolitical tensions and robust corporate earnings, although concerns about potential U.S. tariffs have tempered investor enthusiasm. In this environment, identifying stocks that may be trading below their estimated value can offer potential opportunities for investors seeking to capitalize on market inefficiencies.
XTRA:AG1
XTRA:AG1Specialty Retail

AUTO1 Group (XTRA:AG1) Valuation Check As Record Unit Growth And Cash Position Support Investor Optimism

Earnings context and what just changed AUTO1 Group (XTRA:AG1) has drawn investor attention after reporting first quarter 2026 results, with sales of €2,437.14 million and net income of €26.15 million, alongside record units sold and gross profit. See our latest analysis for AUTO1 Group. The first quarter update arrived alongside a sharp swing in sentiment, with a 1-day share price return of 12.90% and a 7-day share price return of 11.37%, even though the year to date share price return is...
XTRA:SMHN
XTRA:SMHNSemiconductor

SUSS MicroTec (XTRA:SMHN) Is Up 7.7% After Steep Q1 2026 Revenue And Earnings Decline – Has The Bull Case Changed?

SUSS MicroTec SE has reported past first-quarter 2026 results showing sales of €86.54 million versus €124.92 million a year earlier, with net income falling to €2.46 million from €16.6 million and basic earnings per share from continuing operations easing to €0.13 from €0.87. This sharp contraction in both revenue and profitability raises questions about how temporary current pressures are and how they interact with earlier expectations for stable margins and recurring revenue. Next, we’ll...
XTRA:EUZ
XTRA:EUZMedical Equipment

Eckert & Ziegler (XTRA:EUZ) Margin Improvement Supports Bullish Earnings Quality Narrative

Eckert & Ziegler (XTRA:EUZ) opened Q1 2026 with revenue of €72.9 million and basic EPS of €0.17, as the stock trades around €14.80. This has put fresh attention on how the quarterly print lines up with the recent run of growth. Over the past year, revenue on a trailing 12 month basis has moved from €295.9 million to €316.7 million, while basic EPS has gone from €0.64 to €0.79. This sets the scene for investors to focus on how the higher net profit margins feed into the quality of the overall...
XTRA:BAYN
XTRA:BAYNPharmaceuticals

Bayer (XTRA:BAYN) Swings To €2.81 EPS Profit And Tests Long‑Running Bearish Narratives

Bayer (XTRA:BAYN) has opened Q1 2026 with total revenue of €13.4 billion and basic EPS of €2.81, marking a sharp contrast with the loss it reported just a few quarters ago. Over the recent quarters, revenue has moved from €11.4 billion in Q4 2025 and €9.7 billion in Q3 2025 to the latest €13.4 billion, while basic EPS has shifted from a loss of €3.82 in Q4 2025 and a loss of €0.98 in Q3 2025 to a profit of €2.81. This sets up a quarter where margins are firmly back in focus and where the...
XTRA:ENR
XTRA:ENRElectrical

Siemens Energy (XTRA:ENR) Profitability Run Rate Faces Test Against Bullish Growth Narratives

Siemens Energy Q2 2026: Earnings Hold Up As Profitability Beds In Siemens Energy (XTRA:ENR) heads into its Q2 2026 earnings discussion with Q1 2026 revenue of €9.7b, basic EPS of €0.79 and net income of €677m setting the tone for the current financial year. Over the past reported periods, revenue has ranged from €8.9b in Q1 2025 to €10.4b in Q4 2025, while basic EPS moved between €0.19 and €0.79 as the business shifted from a loss of €293m in Q4 2024 to consistent profit. With trailing 12...
XTRA:UN0
XTRA:UN0Renewable Energy

Uniper (XTRA:UN0) Margin Rebuild Challenges Bearish Earnings Narratives Heading Into Q1 2026

Uniper (XTRA:UN0) opened 2026 on the back of a sharp reset in its earnings profile, with Q4 2025 revenue at about €16.2b and basic EPS of €1.99, against a trailing twelve month line of €61.1b in revenue and EPS of €3.35 that reflects a very large 370.4% earnings gain over the past year. Over the last two reported quarters, revenue has moved from roughly €11.8b in Q3 2025 to €16.2b in Q4 2025, while quarterly EPS shifted from €0.72 to €1.99. This sets up Q1 2026 against a backdrop of higher...